跳至主要内容
临床试验/CTRI/2009/091/000108
CTRI/2009/091/000108已完成4 期

A randomized comparative study evaluating efficacy and tolerability of injection Diclofenac sodium 75mg/1ml given intradeltoid versus injection Diclofenac sodium 75mg/3ml given intragluteal in the management of post operative pain in obese patients.

Troikaa Pharmaceuticals Limited0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients in the age group of 18 to 65 years
  • Patients of both sexes
  • Patients with BMI greater or equal to 25
  • Patients undergoing operative procedures requiring hospitalization for at least 48 hours
  • Patients with moderate to severe pain at baseline VAS 4 to10

排除标准

  • 1.Patients below 18 years and above 65 years of age
  • 2.Patients with BMI < or = 25
  • 3.OPD patients/ patients requiring hospitalization less than 48 hours
  • 4.Patients with compromised renal function
  • 5.Pregnant and lactating women
  • 6.Patients with history of bronchial asthma, peptic ulceration, bronchitis
  • 7.Patients with coagulation disorders, especially bleeding disorders
  • 8.Mentally retarded patients
  • 9.Unwilling patients
  • 10.Patients with known hypersensitivity to propylene glycol, diclofenac sodium any other NSAIDs or any component of either of the study formulations
  • 11.Patients with a baseline VAS score of 3 or less than 3

研究者

相似试验

To determine the efficacy and safety of Inj... | 临床试验